Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 15 de 15
Filtrer
1.
Clin Transplant ; 38(1): e15164, 2024 01.
Article de Anglais | MEDLINE | ID: mdl-37847603

RÉSUMÉ

INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only definitive curative option for ß-major thalassemia patients (ß-MT). Posterior reversible encephalopathy syndrome (PRES) is a pervasive neurological complication which typically occurs following HSCT. ß-MT patients are prone to a higher PRES incidence due to long-term immunosuppression; thus, it is imperative that these patients are closely monitored for PRES after HSCT. PATIENTS AND METHODS: We included 148 pediatric patients with ß-MT who underwent HSCT between March 2015 and August 2022 in Children's Medical Center. Patients in this study were divided into two groups. The association between PRES and class of ß-MT and other risk factors were assessed and the overall survival rate was determined. RESULTS: Fourteen out of 112 patients (12%) with class I and II ß-MT developed PRES. However, PRES occurred in 11 out of 36 patients (30.5%) with ß-MT-III. Our results indicated that there was a significant association between class III ß-MT and the occurrence of (P = .004). Additionally, acute graft-versus-host disease (aGVHD) occurred in 80% and 44.7% of patients in the PRES and non-PRES groups, respectively (P = .001). The results of the Kaplan-Meier analysis revealed that the 5-year overall survival (OS) was 75.6% in the PRES group versus 95% in the non-PRES group, which was statistically significant (P = .001). CONCLUSION: Based on our results, pediatric ß-MT III patients are at a higher risk of developing PRES. Additionally, pediatric ß-MT patients with a history of aGVHD, regardless of disease class, are more likely to develop PRES. Considering these results, PRES has a higher chance of being the etiology of symptoms and should be considered more often in these patients.


Sujet(s)
Maladie du greffon contre l'hôte , Transplantation de cellules souches hématopoïétiques , Leucoencéphalopathie postérieure , bêta-Thalassémie , Humains , Enfant , Leucoencéphalopathie postérieure/épidémiologie , Leucoencéphalopathie postérieure/étiologie , Leucoencéphalopathie postérieure/diagnostic , Transplantation de cellules souches hématopoïétiques/effets indésirables , Maladie du greffon contre l'hôte/étiologie , Facteurs de risque , bêta-Thalassémie/complications , bêta-Thalassémie/thérapie , Études rétrospectives
2.
Iran J Microbiol ; 15(1): 10-18, 2023 Feb.
Article de Anglais | MEDLINE | ID: mdl-37069903

RÉSUMÉ

Background and Objectives: One of the most prevalent drug-resistant bacteria is methicillin-resistant Staphylococcus epidermidis (MRSE) causing healthcare infections. Previously, a meta-analysis study on the frequency of MRSE was conducted from Mar 2006 to Jan 2016 in Iran. The present study aimed to evaluate the changes in this prevalence in the last 5 years in different cities in Iran. Materials and Methods: Published articles on the frequency of MRSE were collected from the Web of Science, PubMed, Scopus, Google Scholar, Cochrane Library, and Iranian databases from the beginning of 2016 to the end of 2020. Of the 503 records identified, 17 studies met the inclusion criteria, and their extracted data were analyzed using comprehensive meta-analysis version 2.0 (Biostat). Results: The analysis showed that the frequency of MRSE has decreased significantly in the last five years and reached 60.8 [95% confidence interval (95% CI) 54.2-66.9] among culture-positive cases of S. epidermidis in Iran. Conclusion: The noticeable reduction in the prevalence of MRSE in Iran could be due to the improvement of infection control programs and interruption of the pathogen transmission cycle. Another influential reason is the significant reduction in methicillin prescriptions by physicians for infections caused by staphylococci.

3.
Infect Disord Drug Targets ; 23(1): e280922209259, 2023.
Article de Anglais | MEDLINE | ID: mdl-36173060

RÉSUMÉ

BACKGROUND: Staphylococcus aureus is a human pathogen causing nosocomial infections and increased hospitalization and mortality among human communities. Methicillin-resistant S. aureus strains are considered a severe threat in nosocomial infections and cause complications in the remedy process of bacterial infections. In this study, 137 samples were collected from different departments, staff, and patients in Ilam hospital. METHODS: Eighty-eight samples of these strains were examined to test antibiotic resistance and diffusion. MIC (minimum inhibitory concentration) and PCR (polymerase chain reaction) were performed on the samples resistant to oxacillin. 36 (40.9%) strains were MRSA, and 52 (59.1%) isolates were MSSA. 44.4% of MRSA strains with IV SCCmec type. RESULTS: Fourteen different spa types were found using spa typing, of which the most abundant types were t037, t030, and t701, and three new types, including t15471, t15474, and t17470, were identified among the strains. The molecular analysis by MLST showed that the strains are classified into 11 different sequence types. Sequence type 239 and clonal complexes of 329 and 22 were dominant. ST239- spat037-SCCmec III was also identified as the most frequent clone of MRSA. The most identified clones were MRSA ST239-spa t037-SCCmec III. CONCLUSION: The results show the spa-type distribution between samples of patients, personnel, and surfaces, demonstrating MRSA circulation between patients and the environment. The results show the need to control environmental health.


Sujet(s)
Infection croisée , Staphylococcus aureus résistant à la méticilline , Infections à staphylocoques , Humains , Staphylococcus aureus/génétique , Épidémiologie moléculaire , Méticilline , Typage par séquençage multilocus , Iran/épidémiologie , Infections à staphylocoques/épidémiologie , Infections à staphylocoques/microbiologie , Infection croisée/épidémiologie , Infection croisée/microbiologie , Hôpitaux universitaires , Tests de sensibilité microbienne , Antibactériens/pharmacologie
4.
World J Microbiol Biotechnol ; 38(7): 125, 2022 Jun 03.
Article de Anglais | MEDLINE | ID: mdl-35657493

RÉSUMÉ

Biofilm formation and antibiotic efflux are two determinant factors in the development of drug resistance phenotype by Pseudomonas aeruginosa. Non-steroid anti-inflammatory drugs have shown the antimicrobial potential to be used in combination with antibiotics against bacterial pathogens. In this work, the effect of ibuprofen alone and in combination with ciprofloxacin on some virulence traits and the expression of the alginate synthesis and efflux pump genes of clinical isolates of P. aeruginosa was investigated. The checkerboard titration assay was used to evaluate the synergism of the drugs. P. aeruginosa strains were grown in the presence of sub-inhibitory concentrations of the drug and their biofilm formation level, swarming, swimming, and hemolytic activity were assessed. Also, the relative expression of the alg44, algT/U, mexB, and oprM genes was determined by qPCR assay. The MIC of ibuprofen and ciprofloxacin were measured 2048 and 32 µg/mL and the drugs showed synergic antibacterial activity (FIC = 0.4). Moreover, ibuprofen alone and in combination with ciprofloxacin, significantly reduced the expression of alg44 (0.22 and 0.25 folds) and algT/U (0.26 and 0.37 folds) genes, while increased the expression of the mexB (1.64 and 1.83 folds) and oprM (1.36 and 1.92 folds) genes. Simultaneous treatment of bacterial cells with ibuprofen and ciprofloxacin significantly decreased bacterial biofilm formation (65%), swimming, swarming, and hemolytic activity (85%), compared with the control. This work suggests that ibuprofen has considerable anti-virulence potential against P. aeruginosa and could be employed for combination therapy with antibiotics after further characterizations.


Sujet(s)
Infections à Pseudomonas , Pseudomonas aeruginosa , Antibactériens/métabolisme , Antibactériens/pharmacologie , Protéines de la membrane externe bactérienne/génétique , Ciprofloxacine/pharmacologie , Humains , Ibuprofène/métabolisme , Ibuprofène/pharmacologie , Protéines de transport membranaire/génétique , Protéines de transport membranaire/métabolisme , Tests de sensibilité microbienne , Phénotype , Infections à Pseudomonas/traitement médicamenteux , Virulence/génétique
5.
J Invasive Cardiol ; 33(3): E156-E163, 2021 Mar.
Article de Anglais | MEDLINE | ID: mdl-33472991

RÉSUMÉ

OBJECTIVES: We aimed to investigate the safety of same-day discharge (SDD) after percutaneous coronary intervention (PCI) for non-ST segment elevation acute coronary syndrome (NSTEACS), and to investigate the reduction in duration of hospitalization achievable by SDD. BACKGROUND: Previous studies have established the safety of SDD after elective PCI, while the safety of SDD after non-elective PCI for acute coronary syndrome has only been sparsely studied. METHODS: A single-center, observational, retrospective study of 923 consecutive procedures in patients with NSTEACS who had PCI was performed. The procedures were divided into 2 groups based on postprocedural management: SDD (n = 195) and non-SDD (n = 728). RESULTS: No differences were seen in the total number of adverse events at 1 month (1.5% SDD vs 1.4% non-SDD; P=.74), 3 months (2.5% SDD vs 2.3% non-SDD; P=.80), and 6 months (3.5% SDD vs 3.3% non-SDD; P=.84) after discharge, and there were no deaths in the SDD group. No difference was found in unplanned rehospitalizations within 6 months (20.5% SDD vs 25.3% non-SDD; P=.17), while unplanned revascularizations were more frequent in non-SDD patients (5.6% SDD vs 13.4% non-SDD; P<.01). Median duration of hospitalization was 1.3 days shorter for SDD patients than for non-elderly, uncomplicated non-SDD patients. CONCLUSIONS: SDD after PCI in a selected group of NSTEACS patients was associated with low rates of adverse events, unplanned rehospitalizations, and revascularizations. SDD was associated with a shorter hospitalization duration.


Sujet(s)
Syndrome coronarien aigu , Intervention coronarienne percutanée , Syndrome coronarien aigu/diagnostic , Syndrome coronarien aigu/chirurgie , Humains , Durée du séjour , Adulte d'âge moyen , Sortie du patient , Intervention coronarienne percutanée/effets indésirables , Études rétrospectives , Résultat thérapeutique
6.
Avicenna J Phytomed ; 10(3): 273-286, 2020.
Article de Anglais | MEDLINE | ID: mdl-32523882

RÉSUMÉ

OBJECTIVE: Effects of cotreatment with Urtica dioica (UD) methanolic leaf extract on gentamicin (GM)-induced acute kidney injury were evaluated in rats. MATERIALS AND METHODS: Male Wistar rats (n=32) were separated into four groups. Gentamicin (100 mg/kg/day, IP) was injected for eight days with or without UD methanolic extract (200 mg/kg/day, gavage).  The renal blood flow (RBF) and systolic blood pressure of rats were recorded. Concentration of creatinine, blood urea nitrogen (BUN), sodium, and potassium and osmolarity were measured in the urine and plasma samples. Oxidative stress level was determined by assessment of the levels of antioxidant power (FRAP) and lipid peroxidation (MDA) in the renal tissue. The renal injury and histopathological changes in the kidney were determined by microscopic evaluations. RESULTS: Administration of UD extract along with GM, compared to GM group, significantly decreased the amounts of plasma creatinine and BUN, urinary sodium excretion, fractional excretion of sodium and potassium, and MDA levels but significantly increased creatinine clearance, urine osmolarity, renal blood flow and FRAP levels. CONCLUSION: The cotreatment of UD extract can attenuate renal injury of GM by reduction of oxidative stress, lipid peroxidation, and oxygen free radicals. The potential nephroprotective effects of UD extract are probably mediated via its antioxidant and anti-inflammatory activity.

7.
Int Orthod ; 17(4): 643-651, 2019 12.
Article de Anglais | MEDLINE | ID: mdl-31451344

RÉSUMÉ

OBJECTIVE: Non-syndromic cleft lip/palate (NSCL/P) has a multifactorial and polygenic aetiology. The role of genetics in its occurrence has not been fully clarified. The present meta-analysis aimed to evaluate the association of betaine-homocysteine S-methyltransferase (BHMT) polymorphisms (rs3797546 and rs3733890) with the risk of NSCL/P. MATERIALS AND METHODS: PubMed/Medline, Scopus, Cochrane Library, and Web of Science databases were systematically searched for articles published up until December 2018 with no language restriction. Quality evaluation of each study was performed by the Newcastle-Ottawa Scale (NOS). The crude odds ratio (OR) and 95% confidence interval (CI) were calculated for each study by RevMan 5.3 software, and a funnel plot analysis was performed by the CMA 2.0 software using the Egger's and Begg's tests. RESULTS: Review of the four selected studies revealed that the CC genotype of rs3797546 polymorphism significantly increased the risk of NSCL/P. No association was noted between NSCL/P risk and rs3733890 polymorphism except in Chinese (elevated risk of NSCL/P) and Polish (decreased risk of NSCL/P) populations. CONCLUSIONS: According to the present meta-analysis, rs3733890 polymorphism does not play a role in susceptibility to NSCL/P; whereas, rs3797546 polymorphism may play a role in susceptibility to NSCL/P. Future studies are required to examine the association between BHMT polymorphisms and the NSCL/P risk in different ethnicities with a larger sample size.


Sujet(s)
Betaine-homocysteine S-methyltransferase/génétique , Bec-de-lièvre/génétique , Fente palatine/génétique , Prédisposition génétique à une maladie/génétique , Polymorphisme génétique , Bec-de-lièvre/complications , Bec-de-lièvre/enzymologie , Fente palatine/complications , Fente palatine/enzymologie , Bases de données factuelles , Génotype , Humains , Odds ratio , Facteurs de risque
8.
Drug Res (Stuttg) ; 69(11): 612-620, 2019 Oct.
Article de Anglais | MEDLINE | ID: mdl-31315134

RÉSUMÉ

BACKGROUND: Ischemia-reperfusion (I-R) leads to acute kidney injury (AKI). The present study investigated the effects of nitroglycerine (NG) on improving renal dysfunctions caused by I-R in rats. METHODOLOGY: Twenty-four rats were equally divided into four groups: (1) the control group, (2) the sham group, (3) the I-R group, and (4) NG-treated groups.NG (50 µg/kg) was injected intraperitoneally after induction of IR. I-R was induced through clamping of the bilateral renal artery and vein of both kidneys for 20 min followed by 24 h of reperfusion. RESULTS: NG significantly increased the creatinine clearance levels and renal blood flow rate (which was reduced by I-R). NG also significantly improved serum electrolytes (sodium and potassium) that were disordered by I-R. In addition, NG significantly offset impaired antioxidant defense mechanism and inhibited lipid peroxidation. CONCLUSIONS: The results show NG has a protective effect on renal tissue against AKI caused by I-R. These protective effects mediated through antioxidant activity and decrease of lipid peroxidation.


Sujet(s)
Rein/effets des médicaments et des substances chimiques , Nitroglycérine/pharmacologie , Lésion d'ischémie-reperfusion/traitement médicamenteux , Atteinte rénale aigüe/traitement médicamenteux , Atteinte rénale aigüe/métabolisme , Animaux , Antioxydants/métabolisme , Créatinine/sang , Électrolytes/sang , Rein/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mâle , Nitroglycérine/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Potassium/sang , Agents protecteurs/pharmacologie , Rats , Rat Wistar , Débit sanguin régional/effets des médicaments et des substances chimiques , Lésion d'ischémie-reperfusion/sang , Lésion d'ischémie-reperfusion/métabolisme , Sodium/sang
9.
Drug Res (Stuttg) ; 68(7): 387-394, 2018 Jul.
Article de Anglais | MEDLINE | ID: mdl-29341028

RÉSUMÉ

BACKGROUND: Nephrotoxicity is the major side effects of aminoglycoside antibiotics such as gentamicin. The aim of this study was to investigate the therapeutic effects of Z.multiflora (ZM) hydroalcoholic extract on gentamicin-induced nephrotoxicity. METHODS: Twenty-eight male Wistar rats categorized into four groups: 1) the control group without injection, 2) the gentamicin treated group (100 mg/kg, i.p) 3) the gentamicin and Z. Multiflora treated group; Z. Multiflora extract(0.8 mg/ml in the drinking water) administered after gentamicin (100 mg/kg, i.p) 4) the normal saline and Z. Multiflora treated group; Z. Multiflora extract (0.8 mg/ml in the drinking water) administered after normal saline injection (2 ml/kg,i.p ). RESULTS: Post-treatment with ZM extract caused a significant reduction in the levels of plasma creatinine and blood urea nitrogen (BUN), absolute and fractional excretion of sodium, malondialdehyed (MDA) level in comparison to gentamicin group. In addition, ZM extract significantly increased creatinine clearance, urine osmolarity, and Renal blood flow (RBF) and the Ferric reducing ability of plasma (FRAP) level which had decreased compared to the control group as a result of treatment with gentamicin. CONCLUSION: The above result indicated that ZM extract improved renal toxicity of gentamicin via reducing oxidative stress, oxygen-free radicals, and lipid peroxidation.


Sujet(s)
Gentamicine/pharmacologie , Maladies du rein/induit chimiquement , Maladies du rein/traitement médicamenteux , Rein/effets des médicaments et des substances chimiques , Lamiaceae/composition chimique , Extraits de plantes/pharmacologie , Animaux , Azote uréique sanguin , Créatinine/sang , Maladies du rein/sang , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mâle , Stress oxydatif/effets des médicaments et des substances chimiques , Phytothérapie/méthodes , Rats , Rat Wistar
10.
Aust Endod J ; 44(3): 255-259, 2018 Dec.
Article de Anglais | MEDLINE | ID: mdl-28868797

RÉSUMÉ

The aim of this study was to investigate the effect of human blood exposure on the compressive strength of various calcium silicate-based cements. Two hundred and eighty-eight customised cylindrical moulds were randomly divided into three groups according to material used: ProRoot MTA, Biodentine or CEM cement (n = 96). Each group was divided into two subgroups according to exposure conditions: PBS or blood. Then, the compressive strength of the specimens was measured after 6 h, 24 h, 72 h and 7 days. The compressive strength of CEM cement could not be measured after 6 and 24  h regardless of the exposure conditions nor could the compressive strength of 6 h blood-exposed ProRoot MTA. The compressive strength of blood-exposed ProRoot MTA was only significantly lower after 6 h, but no difference was seen at other time intervals. Blood exposed did adversely affected the compressive strength of Biodentine. The compressive strength of all groups significantly increased over time (P < 0.005).


Sujet(s)
Sang , Composés du calcium/composition chimique , Résistance à la compression/physiologie , Ciments dentaires/composition chimique , Test de matériaux/méthodes , Silicates/composition chimique , Humains , Modèles dentaires , Valeurs de référence , Facteurs temps
11.
Drug Res (Stuttg) ; 67(12): 710-718, 2017 Dec.
Article de Anglais | MEDLINE | ID: mdl-28898907

RÉSUMÉ

Background The main side effect of gentamicin is nephrotoxicity. The effect of cobalamin (Cob) was investigated on gentamicin nephrotoxicity in rats. Methods Renal injury induced by i.p. injection of gentamicin (100 mg/kg) for 8 consecutive days. Cobalamin (6 mg/kg/day, i.p) treatment was done for 8 consecutive days as co-treatment and post-treatment protocol. Results Cobalamin significantly increased creatinine clearance levels and renal blood flow which were reduced by gentamicin. Also, cobalamin significantly improved serum electrolytes (sodium and potassium) levels which were disturbed by gentamicin. Cobalamin significantly compensated deficits in the antioxidant defense mechanisms, suppressed lipid per oxidation and ameliorated renal tissue damage mediated by gentamicin. Conclusion The results of the current study indicated that cobalamin effectively protected the kidney tissue against gentamicin induced acute nephrotoxicity in rats. The antioxidant and anti-inflammatory activities can be supposed the main factors responsible for the nephroprotective effect of cobalamin.


Sujet(s)
Atteinte rénale aigüe/prévention et contrôle , Gentamicine/effets indésirables , Agents protecteurs/pharmacologie , Vitamine B12/pharmacologie , Atteinte rénale aigüe/induit chimiquement , Atteinte rénale aigüe/anatomopathologie , Animaux , Pression sanguine/effets des médicaments et des substances chimiques , Créatinine/sang , Créatinine/urine , Rein/anatomopathologie , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mâle , Potassium/sang , Potassium/urine , Rats , Sodium/sang , Sodium/urine , Urée/sang , Urée/urine
12.
J Biomed Mater Res A ; 105(7): 2047-2055, 2017 Jul.
Article de Anglais | MEDLINE | ID: mdl-28296041

RÉSUMÉ

With the ever-increasing use of carbon nanotubes (CNTs) in health-related and engineering applications, the hazardous risks of this material have become a major concern. It is well known that CNTs accumulate with cytotoxic and genotoxic levels within vital organs. It has also been shown that treating cell cultures with CNTs resulted in cell-cycle arrest and increased apoptosis/necrosis. The goal of this pilot study is to perform a comprehensive comparative study on the toxicity of single-wall (SW) and multiwall (MW) CNTs in rat skin cells. Our results confirm a dose-dependent toxicity of SWCNTs and MWCNTs due to the loss of mitochondrial activity, increase in mitochondrial reactive oxygen species (ROS) formation, and mitochondrial membrane potential collapse before mitochondrial swelling. Moreover, disturbance in the oxidative phosphorylation is observed by a decrease in ATP level. These events induced the release of cytochrome c via outer membrane rupture or MPT pore opening and subsequently programmed cell death of all doses compared to control group. Our results demonstrate that although MWCNTs can be very toxic, SWCNTs cause more mitochondrial damage to the cells. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2047-2055, 2017.


Sujet(s)
Apoptose , Points de contrôle du cycle cellulaire , Mitochondries/métabolisme , Nanotubes de carbone/composition chimique , Stress oxydatif , Animaux , Mâle , Souris , Rats
13.
J Infect Public Health ; 8(6): 533-42, 2015.
Article de Anglais | MEDLINE | ID: mdl-26111484

RÉSUMÉ

The aim of this study was to analyze antimicrobial resistance patterns and their encoding genes and genotypic diversity of Acinetobacter baumannii isolated from burn patients in Tehran, Iran. The presence of extended-spectrum beta-lactamase- and blaOXA-encoding genes among 37 multidrug resistant (MDR) A. baumannii strains isolated from patients hospitalized in a teaching hospital in Tehran was evaluated. Susceptibility to 7 antibiotics was tested by disk agar diffusion and to polymyxin B and colistin was tested by E-test, according to CLSI guidelines. All isolates were then analyzed by PCR for the presence of blaIMP, blaVIM, blaSIMblaOXA-23, blaOXA-24, and blaOXA-58-like carbapenemase genes, and blaOXA-51-like, blaTEM, blaSHV, blaPER, blaVEB, and blaGIM genes. Genotyping of A. baumannii strains was performed by repetitive sequence-based (REP)-PCR and cluster analysis of REP-PCR profiles. A. baumannii isolates were assigned to international clones by multiplex PCR sequence group analysis. Twenty-five A. baumannii isolates were classified as MDR, and 12 were classified as extensively drug resistant. All isolates were susceptible to colistin and polymyxin B. Eighty-one percent of the isolates was resistant to imipenem or meropenem and harbored at least one or both of the blaOXA-23-like or blaOXA-24-like carbapenemase genes. Co-existence of different resistance genes was found among carbapenem-resistant isolates. Multiplex PCR sequence group analysis most commonly assigned A. baumannii isolates to international clones I (18/37; 48.6%) and II (18/37; 48.6%). An alarming increase in resistance to carbapenems and the spread of blaOXA-23-like and/or blaOXA-24-like carbapenemase genes was observed among A. baumannii strains belonging to clonal lineages I and II, isolated from burn patients in Tehran.


Sujet(s)
Infections à Acinetobacter/microbiologie , Acinetobacter baumannii/classification , Acinetobacter baumannii/enzymologie , Protéines bactériennes/génétique , Brûlures/complications , Génotype , bêta-Lactamases/génétique , Infections à Acinetobacter/épidémiologie , Acinetobacter baumannii/génétique , Acinetobacter baumannii/isolement et purification , Antibactériens/pharmacologie , Analyse de regroupements , Tests d'agents antimicrobiens par diffusion à partir de disques , Multirésistance bactérienne aux médicaments , Hôpitaux d'enseignement , Humains , Iran/épidémiologie , Mâle , Typage par séquençage multilocus , Réaction de polymérisation en chaîne , Études rétrospectives
14.
Environ Monit Assess ; 184(3): 1221-30, 2012 Mar.
Article de Anglais | MEDLINE | ID: mdl-21494828

RÉSUMÉ

Regarding various types of pollutant, waste management requires high attention. Environmental site selection study, prior to landfill operation, and subsequently, monitoring and maintaining of the location, are of foremost points in landfill site selection process. By means of these studies, it is possible to control the undesirable impacts caused by landfills. Study ahead aims at examination of effectiveness of a new method called Monavari 95-2 in landfill site assessment. For this purpose, two landfills Rasht and Andisheh, which are, respectively, located on humid and arid areas, were selected as case studies. Then, the results obtained from both sites were compared with each other to find out the weaknesses and strengths of each site. Compared with others similar methods, much more criteria (53 parameters) can be considered within this method, so the results will be more calculable. According to this method, Rasht landfill (site H) is classified as unacceptable landfill site i.e. there is an urgent need for a new suitable site for landfill, while Andishe Landfill (site D) is ranked as acceptable landfill site but needs environmental management program to handle the existing weaknesses.


Sujet(s)
Surveillance de l'environnement/méthodes , Polluants environnementaux/analyse , Élimination des déchets , Villes , Surveillance de l'environnement/normes , Pollution de l'environnement/statistiques et données numériques , Iran , Pluie , Appréciation des risques/méthodes
15.
Biol Trace Elem Res ; 147(1-3): 1-7, 2012 Jun.
Article de Anglais | MEDLINE | ID: mdl-22144015

RÉSUMÉ

Bronchopulmonary dysplasia (BPD), also known as chronic lung disease, is one of the most challenging complications in premature newborn infants. Selenium plays a role in antioxidant system by protecting cell membranes and neutralizing the deleterious effects of free radicals. The aim of this study was to determine the relationship between selenium concentration and incidence of bronchopulmonary dysplasia using a validated analytical method. Umbilical cord blood and blood samples 30 days after the birth were collected from 38 preterm newborn infants with gestation age of 32 weeks or less, and the separated serums were kept at -70°C until analysis time. Selenium concentration of serum was determined using an atomic absorption spectrophotometer. The method was validated on the basis of standard validation techniques. The analytical method was linear in the range of 1 to 500 µg/L with the limit of detection of 0.4 µg/L. Samples were collected from 38 infants whose gestation age was 32 weeks or less. The blood samples were collected from the umbilical cord blood at birth in 19 cases. In 25 cases, blood samples were collected 1 month after birth. Of the 15 patients diagnosed with BPD, 10 were boys (p = 0.02). The mean serum selenium concentration was not different at birth between patients with and without BPD, but it was significantly lower at 30 days after birth in patients with BPD (38.5 ± 14.1vs. 45.4 ± 18.7 µg/L, p = 0.02). Preterm newborn infants with BPD had lower serum selenium concentrations 1 month after birth.


Sujet(s)
Dysplasie bronchopulmonaire/sang , Prématuré/sang , Sélénium/sang , Spectrophotométrie atomique/méthodes , Dysplasie bronchopulmonaire/diagnostic , Sang foetal/composition chimique , Âge gestationnel , Humains , Nouveau-né , Reproductibilité des résultats , Sensibilité et spécificité , Spectrophotométrie atomique/instrumentation
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...